The Company’s business model of product development follows a three-wave approach. The first ‘wave’ resulted in the development of an international business with a product portfolio that addressed the Ear, Nose and Throat (ENT) surgery market. This portfolio was sold to Stryker in 2014 and as part of the agreement, Polyganics continues manufacturing these products in the coming years. The second and third waves are focusing on Peripheral Nerve Repair (PNR) & neurosurgery, and General Surgery markets respectively.
Polyganics’ portfolio includes products developed in-house and in collaboration with leading medical technology companies and academic centers of excellence. In the Peripheral Nerve Repair (PNR) and neurosurgery field, the portfolio includes two marketed products:
In the field of Ear, Nose & Throat (ENT) surgery, we successfully developed, commercialized and sold a portfolio of sinunasal dressings, including NASOPORE, HEMOPORE, OTOPORE and SINUPORE to Stryker.
Products in development include a: